1. Home
  2. CTKB vs DHC Comparison

CTKB vs DHC Comparison

Compare CTKB & DHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTKB
  • DHC
  • Stock Information
  • Founded
  • CTKB 1990
  • DHC 1998
  • Country
  • CTKB United States
  • DHC United States
  • Employees
  • CTKB N/A
  • DHC N/A
  • Industry
  • CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • DHC Real Estate Investment Trusts
  • Sector
  • CTKB Health Care
  • DHC Real Estate
  • Exchange
  • CTKB Nasdaq
  • DHC Nasdaq
  • Market Cap
  • CTKB 697.0M
  • DHC 748.2M
  • IPO Year
  • CTKB 2021
  • DHC N/A
  • Fundamental
  • Price
  • CTKB $5.30
  • DHC $3.21
  • Analyst Decision
  • CTKB Buy
  • DHC Buy
  • Analyst Count
  • CTKB 4
  • DHC 2
  • Target Price
  • CTKB $8.50
  • DHC $6.00
  • AVG Volume (30 Days)
  • CTKB 517.4K
  • DHC 595.5K
  • Earning Date
  • CTKB 08-06-2024
  • DHC 10-30-2024
  • Dividend Yield
  • CTKB N/A
  • DHC 1.25%
  • EPS Growth
  • CTKB N/A
  • DHC N/A
  • EPS
  • CTKB N/A
  • DHC N/A
  • Revenue
  • CTKB $197,711,000.00
  • DHC $1,460,227,000.00
  • Revenue This Year
  • CTKB $8.13
  • DHC N/A
  • Revenue Next Year
  • CTKB $15.93
  • DHC $8.32
  • P/E Ratio
  • CTKB N/A
  • DHC N/A
  • Revenue Growth
  • CTKB 12.60
  • DHC 8.00
  • 52 Week Low
  • CTKB $3.80
  • DHC $1.69
  • 52 Week High
  • CTKB $9.87
  • DHC $3.96
  • Technical
  • Relative Strength Index (RSI)
  • CTKB 43.03
  • DHC 45.28
  • Support Level
  • CTKB $5.20
  • DHC $3.45
  • Resistance Level
  • CTKB $5.50
  • DHC $3.61
  • Average True Range (ATR)
  • CTKB 0.23
  • DHC 0.16
  • MACD
  • CTKB 0.00
  • DHC -0.02
  • Stochastic Oscillator
  • CTKB 16.95
  • DHC 16.07

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

About DHC Diversified Healthcare Trust of Beneficial Interest

Diversified Healthcare Trust is a real estate investment trust that focuses on healthcare-related properties, including life science estates, medical offices, and senior living communities. It acquires and owns properties and is engaged in the development and implementation of medical services and technologies. It operates through two segments: Office Portfolio and SHOP. The office portfolio includes medical office properties leased to medical-related businesses and life sciences properties. The SHOP segment runs communities that offer multiple types of residential care, ranging from independent living to nursing services. DHT operates across the United States and the majority of its revenue derives from rents and medical programs.

Share on Social Networks: